Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk

Rapid Communications in Mass Spectrometry

Volumn 21, Issue 16, 2007, Pages 2693-2703

  Pellegrini, Manuela ^a   Marchei, Emilia ^a   Rossi, Silvia ^a   Vagnarelli, Federica ^b   Durgbanshi, Abhilasha ^c   García Algar, Óscar ^d   Vall, Oriol ^d   Pichini, Simona ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c DR H S GOUR UNIVERSITY   (India)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALIBRATION; CHLORINE COMPOUNDS; COLUMN CHROMATOGRAPHY; ELECTROSPRAY IONIZATION; MASS SPECTROMETRY; METABOLITES; NICOTINE; POSITIVE IONS;

ANALYTES; ARECOLINE; BREAST MILK; COTININE; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN MILK; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; N-OXIDES; TRANS-3'-HYDROXYCOTININE;

CAFFEINE;

EID: 34547857012     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3137     Document Type: Article

References (37)

1. Campoy C, Olea-Serrano F, Jimenez M, Bayes R, Canabate F, Rosales MJ, Blanca E, Olea N. Early Hum. Develop. 2001; 65: S173.
2. Atkinson HC, Begg EJ, Darlow BA. Clin. Pharmacokinetics 1988; 14: 217.
3. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776.
4. Pichini S, Altieri I, Zuccaro P, Pacifici R. Clin. Pharmacokinetics 1996; 130: 211.
5. Steiner E, Villen T, Hallberg M, Rane A. Eur. J. Clin. Pharmacol. 1984; 27: 123.
6. Robieux I, Koren G, Vandenbergh H, Schneiderman J. J. Toxicol. Clin. Toxicol. 1990; 28: 365.
7. Pons G, Rey E, Matheson I. Clin. Pharmacokinet. 1994; 27: 270.
8. Winecker RE, Goldberger BA, Tebbett IR, Behnke M, Eyler FD, Karlix JL, Wobie K, Conlon M, Phillips D, Bertholf RL. J. Forensic Sci. 2001; 46: 1221.
9. Norton SA. J. Am. Acad. Dermatol. 1998; 38: 81.
10. Gupta PC, Ray CS. Ann. Acad. Med. Singapore 2004; 33 (suppl): 31S.
11. Benowitz NL. Prevent. Med. 1997; 26: 412.
12. Golding J. Early Hum. Develop. 1997; 49 (Suppl): S29.
13. Pichini S, Garcia-Algar O. Ther. Drug Monit. 2006; 28: 288.
14. Tuomi T, Johnsson T, Reijula K. Clin. Chem. 1999; 45: 2164.
15. Benowitz NL. Environ. Health Perspect. 1999; 107: 349.
16. Stavchansky S, Combs A, Sagraves R, Delgado M, Joshi A. Biopharmaceut. Drug Dispos. 1988; 9: 285.
17. Koren G. Canadian Family Physician 2000; 46: 801.
18. Aldrige A, Aranda JV, Neims AH. Clin. Pharmacol. Therapeut. 1979; 25: 447.
19. Bailey DN, Weibert RT, Naylor AJ, Shaw RF. J. Anal. Toxicol. 1982; 6: 64.
20. Winstock A. Addiction Biol. 2002; 7: 133.
21. Ahluwalia HS, Ponnampalam JT. Trop. Med. Hyg. News 1968; 71: 48.
22. Yang MJ, Chung TC, Yang MJ, Hsu TY, Ko YC. J. Toxicol. Environ. Health A 2001; 64: 465.
23. Ilett KF, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP. Clin. Pharmacol. Therapeut. 2003; 74: 516.
24. Page-Sharp M, Hale TW, Hackett LP, Kristensen JH, Ilett KF. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003; 796: 173.
25. Aresta A, Palmisano F, Zamborin CG. Food Chem. 2005; 93: 177.
26. Marquet P. Ther. Drug Monit. 2002; 24: 255.
27. Guidance for Industry, Bioanalytical Method validation, US Department of Health and Human Services, Food and Drug Administration, May 2001. Available: http://www.fda.gov/cder/guidance/4252fnl.htm.
28. ICH Topic Q 2 B Validation of analytical procedures: methodology, The European Agency for the Evaluation of Medicinal Products, ICH: London, November 1996. Available: http://www.emea.eu.int/htms/human/ich/quality/ichfin.htm.
29. Linnet K. Clin. Chem. 1993; 39: 424.
30. Meger M, Meger-Kossien I, Schuler-Metz A, Janket D, Scherer G. J. Chromatogr. B 2002; 778: 251.
31. Byrd GD, Davis RA, Ogden MW. J. Chromatogr. Sci. 2005; 43: 133.
32. Williams JP, Nibbering NM, Green BN, Patel VJ, Scrivens JH. J. Mass Spectrom. 2006; 41: 1277.
33. Smyth TJ, Ramachandran VN, McGuigan A, Hopps J, Smyth WF. Rapid Commun. Mass Spectrom 2007; 21: 557.
34. Vagnarelli F, Amarri S, Scaravelli G, Pellegrini M, Garcia-Algar O, Pichini S. Ther. Drug Monit. 2006; 28: 585.
35. Martín I, López-Vílchez MA, Mur A, Garcia-Algar O, Rossi S, Marchei E, Pichini S. Ther. Drug Monit. 2007; 29: 127.
36. Pichini S, Pellegrini M, Pacifici R, Marchei E, Murillo J, Puig C, Vall O, García-Algar O. Rapid Commun. Mass Spectrom. 2003; 17: 1958.
37. Garcia-Algar O, Vall O, Alameda F, Puig C, Pellegrini M, Pacifici R, Pichini S. Archives of Disease in Childhood Fetal and Neonatal Edition 2005; 90: F276.